ONO Pharmaceutical Co's market cap is currently ―. The company's EPS TTM is $1.34; its P/E ratio is ―; and it has a dividend yield of 5.07%. ONO Pharmaceutical Co is scheduled to report earnings on February 3, 2025, and the estimated EPS forecast is $0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 122.32B	$ 109.98B	$ 106.72B	$ 89.93B	$ 97.35B
Gross Profit	$ 92.24B	$ 83.20B	$ 79.78B	$ 67.05B	$ 72.28B
EBIT	$ 43.51B	$ 42.18B	$ 39.32B	$ 21.20B	$ 25.11B
EBITDA	$ 47.83B	$ 46.50B	$ 43.62B	$ 25.83B	$ 29.51B
Net Income Common Stockholders	$ 33.32B	$ 32.86B	$ 29.48B	$ 15.90B	$ 18.33B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 177.03B	$ 163.78B	$ 136.18B	$ 116.97B	$ 110.25B
Total Assets	$ 830.54B	$ 805.01B	$ 764.19B	$ 739.20B	$ 740.06B
Total Debt	$ 8.90B	$ 8.29B	$ 8.65B	$ 8.80B	$ 9.10B
Net Debt	$ -168.14B	$ -155.50B	$ -127.53B	$ -108.17B	$ -101.16B
Total Liabilities	-	-	-	-	-
Stockholders Equity	$ 721.38B	$ 704.52B	$ 671.89B	$ 655.91B	$ 660.67B
Cash Flow	-
Free Cash Flow	$ 29.45B	$ 46.27B	$ 29.30B	$ 32.37B	$ -14.56B
Operating Cash Flow	$ 34.09B	$ 47.90B	$ 33.08B	$ 34.43B	$ -12.97B
Investing Cash Flow	$ -6.93B	$ -36.60B	$ -1.32B	$ -12.02B	$ 23.44B
Financing Cash Flow	$ -15.81B	$ -1.71B	$ -13.36B	$ -16.00B	$ -29.27B

Currency in USD

ONO Pharmaceutical Co Earnings and Revenue History

Income Statement >

ONO Pharmaceutical Co Debt to Assets

Balance Sheet >

ONO Pharmaceutical Co Cash Flow

Cash Flow >

ONO Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing